ibi311
mAbexperimental
Clinical trial activity
10 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
4
Phase 4
3
Earliest trial started Aug 10, 2022 (NCT05480579)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07113262 | Phase 3 | Sep 10, 2025 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT07152392 | Phase 4 | Apr 15, 2025 | Second Military Medical University |
| NCT07152366 | Phase 4 | Apr 15, 2025 | Second Military Medical University |
| NCT07152340 | Phase 4 | Apr 10, 2025 | Second Military Medical University |
| NCT06866548 | Early Phase 1 (Phase 1) | Mar 10, 2025 | Second Military Medical University |
| NCT06525506 | Phase 2 | Sep 4, 2024 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT06269393 | Phase 3 | Jan 1, 2024 | Peking University |
| NCT06126783 | Phase 3 | Oct 20, 2023 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT05795621 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2022 | Innovent Biologics (Suzhou) Co. Ltd. |
| NCT05480579 | Phase 1 | Aug 10, 2022 | Innovent Biologics (Suzhou) Co. Ltd., Jiao Tong University |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | For profit | 5 | 5 | 3 | 2022 |
| Second Military Medical University | Government | 4 | 4 | 2 | 2025 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2024 |
4 organizations
Page 1 / 1